NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024
Buyers
Value
£626,522,476
Suppliers
- Gilead Sciences Limited
- ViiV Healthcare UK Ltd
- Merck Sharpe & Dohme (UK) Limited
- Mawdsley-Brooks & Co Ltd
- ABBVIE LTD
- Janssen-Cilag Ltd
- Lupin Healthcare (UK) Limited
- Dr.Reddy's Laboratories (UK) Limited
- Macleods Pharma UK Limited
- Mylan
- MSN Laboratories Europe Limited
- AMAROX LIMITED
- Milpharm Ltd/aurobinbdo Primary
Classifications
- Pharmaceutical products
Tags
- award
Submission Deadline
8 months ago
Published
1 month ago
Description
Project title: NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) & For the provision of a service to supply over labelled Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Packs for the prevention of HIV (Lot 2) 1st November 2024 Offer reference number: CM/PHS/24/5709 Period of framework agreement: 1st November 2024 to 31st October 2026 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 24 months.
Similar Contracts
Open
Published 3 days ago
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete